[Position of the Drug Committee of German Physicians on vaccination against the new influenza A (H1N1)].
Identifieur interne : 000351 ( Main/Exploration ); précédent : 000350; suivant : 000352[Position of the Drug Committee of German Physicians on vaccination against the new influenza A (H1N1)].
Auteurs :Source :
- Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege [ 0723-2276 ] ; 2009.
Descripteurs français
- KwdFr :
- Adjuvants immunologiques (effets indésirables), Allemagne, Comité médico-pharmaceutique, Conservateurs pharmaceutiques (effets indésirables), Enfant, Facteurs de risque, Femelle, Flambées de maladies (), Grippe humaine (), Grippe humaine (immunologie), Grippe humaine (soins infirmiers), Grossesse, Humains, Sous-type H1N1 du virus de la grippe A (immunologie), Surveillance post-commercialisation des produits de santé, Thiomersal (effets indésirables), Vaccination de masse (soins infirmiers), Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (effets indésirables), Vaccins antigrippaux (immunologie).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- effets indésirables : Adjuvants immunologiques, Conservateurs pharmaceutiques, Thiomersal, Vaccins antigrippaux.
- immunologie : Grippe humaine, Sous-type H1N1 du virus de la grippe A, Vaccins antigrippaux.
- soins infirmiers : Grippe humaine, Vaccination de masse.
- Allemagne, Comité médico-pharmaceutique, Enfant, Facteurs de risque, Femelle, Flambées de maladies, Grippe humaine, Grossesse, Humains, Surveillance post-commercialisation des produits de santé.
- Wicri :
- geographic : Allemagne.
English descriptors
- KwdEn :
- Adjuvants, Immunologic (adverse effects), Child, Disease Outbreaks (prevention & control), Female, Germany, Humans, Influenza A Virus, H1N1 Subtype (immunology), Influenza Vaccines (administration & dosage), Influenza Vaccines (adverse effects), Influenza Vaccines (immunology), Influenza, Human (immunology), Influenza, Human (nursing), Influenza, Human (prevention & control), Mass Vaccination (nursing), Pharmacy and Therapeutics Committee, Pregnancy, Preservatives, Pharmaceutical (adverse effects), Product Surveillance, Postmarketing, Risk Factors, Thimerosal (adverse effects).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- chemical , adverse effects : Adjuvants, Immunologic, Influenza Vaccines, Preservatives, Pharmaceutical, Thimerosal.
- chemical , immunology : Influenza Vaccines.
- geographic : Germany.
- immunology : Influenza A Virus, H1N1 Subtype, Influenza, Human.
- nursing : Influenza, Human, Mass Vaccination.
- prevention & control : Disease Outbreaks, Influenza, Human.
- Child, Female, Humans, Pharmacy and Therapeutics Committee, Pregnancy, Product Surveillance, Postmarketing, Risk Factors.
PubMed: 19953852
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Position of the Drug Committee of German Physicians on vaccination against the new influenza A (H1N1)].</title></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="RBID">pubmed:19953852</idno><idno type="pmid">19953852</idno><idno type="wicri:Area/Main/Corpus">000365</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000365</idno><idno type="wicri:Area/Main/Curation">000365</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000365</idno><idno type="wicri:Area/Main/Exploration">000365</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Position of the Drug Committee of German Physicians on vaccination against the new influenza A (H1N1)].</title></analytic><series><title level="j">Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege</title><idno type="ISSN">0723-2276</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adjuvants, Immunologic (adverse effects)</term><term>Child</term><term>Disease Outbreaks (prevention & control)</term><term>Female</term><term>Germany</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype (immunology)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza Vaccines (adverse effects)</term><term>Influenza Vaccines (immunology)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (nursing)</term><term>Influenza, Human (prevention & control)</term><term>Mass Vaccination (nursing)</term><term>Pharmacy and Therapeutics Committee</term><term>Pregnancy</term><term>Preservatives, Pharmaceutical (adverse effects)</term><term>Product Surveillance, Postmarketing</term><term>Risk Factors</term><term>Thimerosal (adverse effects)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adjuvants immunologiques (effets indésirables)</term><term>Allemagne</term><term>Comité médico-pharmaceutique</term><term>Conservateurs pharmaceutiques (effets indésirables)</term><term>Enfant</term><term>Facteurs de risque</term><term>Femelle</term><term>Flambées de maladies ()</term><term>Grippe humaine ()</term><term>Grippe humaine (immunologie)</term><term>Grippe humaine (soins infirmiers)</term><term>Grossesse</term><term>Humains</term><term>Sous-type H1N1 du virus de la grippe A (immunologie)</term><term>Surveillance post-commercialisation des produits de santé</term><term>Thiomersal (effets indésirables)</term><term>Vaccination de masse (soins infirmiers)</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Vaccins antigrippaux (effets indésirables)</term><term>Vaccins antigrippaux (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Adjuvants, Immunologic</term><term>Influenza Vaccines</term><term>Preservatives, Pharmaceutical</term><term>Thimerosal</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Germany</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Adjuvants immunologiques</term><term>Conservateurs pharmaceutiques</term><term>Thiomersal</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term><term>Sous-type H1N1 du virus de la grippe A</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="nursing" xml:lang="en"><term>Influenza, Human</term><term>Mass Vaccination</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Disease Outbreaks</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="soins infirmiers" xml:lang="fr"><term>Grippe humaine</term><term>Vaccination de masse</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Child</term><term>Female</term><term>Humans</term><term>Pharmacy and Therapeutics Committee</term><term>Pregnancy</term><term>Product Surveillance, Postmarketing</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Allemagne</term><term>Comité médico-pharmaceutique</term><term>Enfant</term><term>Facteurs de risque</term><term>Femelle</term><term>Flambées de maladies</term><term>Grippe humaine</term><term>Grossesse</term><term>Humains</term><term>Surveillance post-commercialisation des produits de santé</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19953852</PMID><DateCompleted><Year>2010</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2016</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0723-2276</ISSN><JournalIssue CitedMedium="Print"><Volume>28</Volume><Issue>11</Issue><PubDate><Year>2009</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege</Title><ISOAbbreviation>Kinderkrankenschwester</ISOAbbreviation></Journal><ArticleTitle>[Position of the Drug Committee of German Physicians on vaccination against the new influenza A (H1N1)].</ArticleTitle><Pagination><MedlinePgn>463-5</MedlinePgn></Pagination><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Stellungnahme der Arzneimittelkommission der deutschen Arzteschaft zur Schutzimpfung gegen die neue Influenza A (H1N1).</VernacularTitle></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Kinderkrankenschwester</MedlineTA><NlmUniqueID>8305989</NlmUniqueID><ISSNLinking>0723-2276</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000276">Adjuvants, Immunologic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011310">Preservatives, Pharmaceutical</NameOfSubstance></Chemical><Chemical><RegistryNumber>2225PI3MOV</RegistryNumber><NameOfSubstance UI="D013849">Thimerosal</NameOfSubstance></Chemical></ChemicalList><CitationSubset>N</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000276" MajorTopicYN="N">Adjuvants, Immunologic</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000451" MajorTopicYN="Y">nursing</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032541" MajorTopicYN="N">Mass Vaccination</DescriptorName><QualifierName UI="Q000451" MajorTopicYN="Y">nursing</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010606" MajorTopicYN="Y">Pharmacy and Therapeutics Committee</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011310" MajorTopicYN="N">Preservatives, Pharmaceutical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011358" MajorTopicYN="N">Product Surveillance, Postmarketing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013849" MajorTopicYN="N">Thimerosal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19953852</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000351 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000351 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeAllemagneV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:19953852
|texte= [Position of the Drug Committee of German Physicians on vaccination against the new influenza A (H1N1)].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:19953852" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV3
| This area was generated with Dilib version V0.6.35. |  |